sibutramine has been researched along with Depression, Endogenous in 6 studies
sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride
| Excerpt | Relevance | Reference |
|---|---|---|
| "Minimal recommended dose of sibutramine induced manic episode that was the first manifestation of bipolar disorder." | 7.78 | Sibutramine-induced mania as the first manifestation of bipolar disorder. ( Simonienko, K; Szajda, SD; Szulc, A; Waszkiewicz, N; Zalewska, A; Zalewska-Szajda, B; Zwierz, K; Ładny, JR, 2012) |
| "Minimal recommended dose of sibutramine induced manic episode that was the first manifestation of bipolar disorder." | 3.78 | Sibutramine-induced mania as the first manifestation of bipolar disorder. ( Simonienko, K; Szajda, SD; Szulc, A; Waszkiewicz, N; Zalewska, A; Zalewska-Szajda, B; Zwierz, K; Ładny, JR, 2012) |
| "Treatment with sibutramine, 15 mg/day, was administered for 12 weeks." | 2.70 | An open-label trial of sibutramine in obese patients with binge-eating disorder. ( Appolinario, JC; Cabral, M; Carraro, L; Coutinho, W; Fontenelle, LF; Godoy-Matos, A; Vieira, A, 2002) |
| "The prevalence of obesity is growing at an alarming rate." | 2.43 | Obesity. ( Fabricatore, AN; Wadden, TA, 2006) |
| "Obesity is a multifactorial, chronic disorder that has reached epidemic proportions in most industrialised countries and is threatening to become a global epidemic." | 1.35 | Sibutramine--its impact on health-related quality of life and depression among adult obese non-diabetic patients. ( Pavlik, V; Slanska, I; Slovacek, L; Slovackova, B, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slovacek, L | 1 |
| Slovackova, B | 1 |
| Pavlik, V | 1 |
| Slanska, I | 1 |
| Waszkiewicz, N | 1 |
| Zalewska-Szajda, B | 1 |
| Szajda, SD | 1 |
| Simonienko, K | 1 |
| Zalewska, A | 1 |
| Szulc, A | 1 |
| Ładny, JR | 1 |
| Zwierz, K | 1 |
| Patten, SB | 1 |
| Fabricatore, AN | 1 |
| Wadden, TA | 1 |
| Appolinario, JC | 1 |
| Godoy-Matos, A | 1 |
| Fontenelle, LF | 1 |
| Carraro, L | 1 |
| Cabral, M | 1 |
| Vieira, A | 1 |
| Coutinho, W | 1 |
| Benazzi, F | 1 |
2 reviews available for sibutramine and Depression, Endogenous
| Article | Year |
|---|---|
Major depressive episodes and diet pills.
Topics: Anti-Obesity Agents; Appetite Depressants; Central Nervous System Stimulants; Cyclobutanes; Depressi | 2002 |
Obesity.
Topics: Appetite Depressants; Bariatric Surgery; Behavior Therapy; Body Mass Index; Body Weight; Chronic Dis | 2006 |
1 trial available for sibutramine and Depression, Endogenous
| Article | Year |
|---|---|
An open-label trial of sibutramine in obese patients with binge-eating disorder.
Topics: Adult; Anxiety Disorders; Appetite Depressants; Bulimia; Comorbidity; Cyclobutanes; Depressive Disor | 2002 |
3 other studies available for sibutramine and Depression, Endogenous
| Article | Year |
|---|---|
Sibutramine--its impact on health-related quality of life and depression among adult obese non-diabetic patients.
Topics: Adult; Aged; Cyclobutanes; Depressive Disorder; Female; Humans; Male; Middle Aged; Obesity; Quality | 2009 |
Sibutramine-induced mania as the first manifestation of bipolar disorder.
Topics: Antidepressive Agents; Bipolar Disorder; Cyclobutanes; Depressive Disorder; Female; Humans; Young Ad | 2012 |
Organic hypomania secondary to sibutramine-citalopram interaction.
Topics: Adult; Appetite Depressants; Bipolar Disorder; Citalopram; Cyclobutanes; Depressive Disorder; Drug I | 2002 |